Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
This summer, we launched a new research work that examined the costs yielded by a reborn and evolved species of the prescription drug supply chain: drug companies who are also part of larger…
Read the full articleYou might also wanna read
States target pharmacy benefit managers with new laws to lower prescription drug costs
Legislators across the U.S. are trying to lower prescription costs by reining in big companies that handle drug coverage for health insurers
States target pharmacy benefit managers with new laws to lower prescription drug costs
Legislators across the U.S. are trying to lower prescription costs by reining in big companies that handle drug coverage for health insurers
Stakeholder Perspectives on the Structural Causes of Drug Shortages in Korea: A Mixed-Methods Study
Background Drug shortages are a persistent global challenge. In South Korea, shortages occur within a distinct context characterized by high
The Hidden Truth Behind Your Supplements
In today's healthcare landscape, we face a challenging reality: the traditional medical system does not always fully support our health. As

Unfair Fees and Low Competition: Why the Pharmacy Sector Needs a Shake-Up
A new report says Australia’s pharmacy sector needs greater competition, transparency, and evidence-based reforms.

Comments
Sign in to join the conversation.
No comments yet. Be the first.